P&S Market Research - A market research firm

Animal Vaccines Market

Global Animal Vaccines Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10004
Available Format:
Category : Biotechnology

Like humans, animals also suffer from several infectious diseases such as rabies and foot and mouth disease. Introduction of advanced veterinary medicines hold prime importance in the treatment of animal diseases. However, prevention of diseases is also essential to provide immunity against various diseases. Prevention is usually done by vaccination. Vaccination also reduces the multiple doses of antibiotics used to control established diseases and has prevented long term suffering and death from diseases.

The global animal vaccines market is segmented based on various products, technologies and animal diseases. Product segment covers companion animal vaccines, poultry, livestock, porcine, aquaculture and equine. The companion animal vaccine sub-segment is further sub-divided into feline vaccines and canine vaccines. The livestock vaccines sub-segment includes bovine vaccines and ruminant vaccines. The livestock vaccines are the largest sub-segment in global animal vaccines market. However, companion vaccine and aquaculture are fastest growing sub-segments in global animal vaccines market.

Based on technology, the market is segmented into live attenuated vaccines, subunit vaccines, in-activated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines and DNA vaccines. DNA vaccine is the fastest growing technology in global animal vaccines market. This is due to factors such as thermo-stability, easy production, cost effectiveness and rapid development against emerging diseases. The animal diseases segment covers rabies, foot and mouth disease, avian influenza, gumboro disease and strangles.

Europe dominates the global animal vaccines market followed by North America. Germany, France and the U.K. are some of the largest markets for animal vaccines in Europe. The U.S., followed by Canada, is the largest market for animal vaccines in North America. The key driving factor for animal vaccines market in these regions is increasing research activities on various types of animal diseases. In addition, increased awareness about animal health also has a strong positive impact on the growth of animal vaccines market in Europe and North America. However, Asia-Pacific represents the fastest growing region in the global animal vaccines market. This is due to minimal wages and availability of skilled professionals in the region. These factors attract vaccines manufacturing companies to invest in the Asian countries. In addition, increasing awareness about animal health also boosts the growth of animal vaccines market in the region. China, Japan and India are the largest animal vaccines markets in the region.

Global animal vaccines market is primarily driven by increasing incidences of zoonotic diseases in humans. Rising prevalence of animal diseases and growing investment by government bodies are also enhancing the growth of global animal vaccines market. In addition, technological innovations and introduction of innovative vaccines, such as DNA, are recombinant vaccines, and have fueled the growth of animal vaccines market. Furthermore, improving animal healthcare facilities in developed and developing parts of the world provides opportunity for the global animal vaccines market.

However, patent expiry of various major vaccines and increasing maintenance costs for vaccines are key restraints of this market. Stringent regulations and legislations and shift towards vegetarian food by consumers also obstruct the growth of global animal vaccines market. Rapid product launches and increasing mergers and acquisitions between vaccines manufactures are emerging trends of the global animal vaccines market.

Some of the major competitors in the market include Pfizer, Sanofi-Aventis, Bayer HealthCare, Novartis, Boehringer Ingelheim, Ceva, Heska Corporation, Bioniche Animal Health Canada Inc. and Virbac.

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis

  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market

  • Uncovers potential demands in the market

  • Porter analysis identifies competitive forces within the market

  • Provides information on the historical and current market size and the future potential of the market

  • Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable)

  • Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger & acquisitions

  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry